Skip to content
Back to MRVI

Maravai Lifesciences Holdings, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
4
Purchases
2
Sales
2
Purchase value
$368.54K
Sale value
$254.00K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Kurt OreshackGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed Jun 10, 2026Period of report Jun 9, 20260001832579-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 10, 2026
Class A Common StockF125,000$5.10$127.50K335,767Direct
SaleJun 9, 2026
Class A Common StockF125,000$5.06$126.50K360,767Direct
Filing footnotes · 1
  1. F1The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
Open on SEC EDGAR
Gregory T LucierDirector
4
Filed Dec 9, 2025Period of report Dec 5, 20250001251299-25-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 8, 2025
Class A Common StockF248,528$3.67$178.10K155,123Direct
PurchaseDec 5, 2025
Class A Common StockF151,472$3.70$190.45K106,595Direct
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.679 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.